| Literature DB >> 27303743 |
Sandrine Stutzmann1, Melanie Blokesch1.
Abstract
Vibrio cholerae, the causative agent of cholera, is a model organism for studying virulence regulation, biofilm formation, horizontal gene transfer, and the cell-to-cell communication known as quorum sensing (QS). As in any research field, discrepancies between data from diverse laboratories are sometimes observed for V. cholerae. Such discrepancies are often caused by the use of diverse patient or environmental isolates. In this study, we investigated the inability of a few laboratories to reproduce high levels of natural transformation, a mode of horizontal gene transfer that is specifically induced on chitinous surfaces. This irreproducibility was mostly related to one specific isolate of V. cholerae: the O1 El Tor C6706 strain. C6706 was previously described as QS proficient, an important prerequisite for the induction of natural competence for transformation. To elucidate the underlying problem, we collected seven isolates of the same C6706 strain from different research laboratories in North America and Europe and compared their phenotypes. Importantly, we observed a split response with respect to QS-related gene expression, including chitin-induced natural competence and type VI secretion (T6S). While approximately half of the strains behaved as reported for several other O1 El Tor pandemic isolates that are commonly studied in the laboratory, the other half were significantly impaired in QS-related expression patterns. This impairment was caused by a mutation in a QS-related gene (luxO). We conclude that the circulation of such QS-impaired wild-type strains is responsible for masking several important phenotypes of V. cholerae, including natural competence for transformation and T6S. IMPORTANCE Phenotypic diversity between laboratory-domesticated bacterial strains is a common problem and often results in the failed reproduction of published data. However, researchers rarely compare such strains to elucidate the underlying mutation(s). In this study, we tested one of the best-studied V. cholerae isolates, O1 El Tor strain C6706 (a patient isolate from Peru), with respect to two main phenotypes: natural competence for transformation and type VI secretion. We recently demonstrated that the two phenotypes are coregulated and specifically induced upon the growth of pandemic V. cholerae O1 El Tor strains on chitinous surfaces. We provide evidence that of seven C6706 strains collected from different laboratories, four were impaired in the tested phenotypes due to a mutation in a QS gene. Collectively, our data indicate that the circulation of such a mutated wild-type strain of C6706 might have had important consequences for QS-related data.Entities:
Keywords: Vibrio cholerae; luxO mutation; natural competence for transformation; quorum sensing; type VI secretion system
Year: 2016 PMID: 27303743 PMCID: PMC4888887 DOI: 10.1128/mSphere.00098-16
Source DB: PubMed Journal: mSphere ISSN: 2379-5042 Impact factor: 4.389
FIG 1 TfoX- and quorum-sensing (QS)-dependent regulation of the DNA-uptake machinery and the type VI secretion system (T6SS) in V. cholerae. The scheme shows the TfoX- and QS-dependent regulation of the competence regulon in V. cholerae, which includes genes encoding the DNA-uptake machinery and the T6SS. The activation of most genes requires dual input from chitin and a high cell density (HCD; compared with low cell density, LCD), which results in the production of the transformation regulator TfoX and the main regulator of QS, HapR, respectively. The signals of both of these proteins merge in the expression of qstR, which encodes the QS- and TfoX-dependent transcription factor QstR. TfoX, HapR, and QstR are required for the production of the essential parts of the DNA-uptake machinery and the T6SS (shown by orange arrows), whereas the type IV pilus part of the DNA-uptake machinery relies solely on the activation by TfoX (green arrow). QS-impaired C6706 mutant strains possess reduced HapR levels and, accordingly, reduced expression of the QstR-regulated genes. Natural transformation and T6SS-mediated interbacterial killing are therefore vastly impaired. The genes whose expression levels were measured in this study are in bold. LuxO~P, phosphorylated LuxO.
FIG 2 The seven samples of strain C6706 are transformation variable. The seven representatives of strain C6706 (and strain A1552 as a control) were grown on chitin flakes and scored for natural transformability. The data represent the average transformation frequencies of at least three biological replicates (±SD), and the dashed line shows the value for the A1552 control strain. If no transformants were recovered in a subset of the independent experiments, the detection limit value was used for calculations (indicated by the white exclamation mark). Statistically significant differences between the results from the different C6706 strains and the A1552 control strain were determined by Student’s t test (*, P < 0.05; **, P < 0.01; n.s., not significant).
FIG 3 Two different patterns exist for the expression of QS-responsive genes in the seven C6706 samples. Data represent the relative expression levels of hapR and selected HapR-regulated genes (see Fig. 1 for details) as measured by qRT-PCR. Different V. cholerae C6706 strains (strain 1 to strain 7) were cultured in liquid LB medium to an HCD (A) or were statically grown on chitinous surfaces (B). Strain A1552 served as the positive control. The data represent the means (±SD) of the results of three independent biological experiments. Statistical differences between the A1552 control strain and the indicated C6706 strains (strain 1 to strain 7) were determined using two-way ANOVA. Only significantly different values are indicated: *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.
Sequenced luxO and hapR genes in commonly studied V. cholerae strains
| Description of | Description of | |
|---|---|---|
| A1552 (O1) | Wild-type sequence | Wild-type |
| C6706#1 (O1) | Wild-type sequence | Wild-type sequence |
| C6706#2 (O1) | Mutant | Wild-type sequence |
| C6706#3 (O1) | Mutant | Wild-type sequence |
| C6706#4 (O1) | Mutant | Wild-type sequence |
| C6706#5 (O1) | Mutant | Wild-type sequence |
| C6706#6 (O1) | Wild-type sequence | Wild-type sequence |
| C6706#7 (O1) | Wild-type sequence | Wild-type sequence |
| N16961 (O1) | Wild-type sequence | Frameshift mutation in |
| N16961rep (O1) | Wild-type sequence | Wild-type sequence (frameshift mutation of strain N16961 repaired) |
| C6709 (O1) | Wild-type sequence | Wild-type sequence |
| E7946 (O1) | Wild-type sequence | Wild-type sequence |
| DRC-193A (O1) | Wild-type sequence | Wild-type sequence |
| P27459 (O1) | Wild-type sequence | Wild-type sequence |
| O395 (O1 classical) | Wild-type sequence | Frameshift mutation in |
| 569B (O1 classical) | Wild-type sequence | Mutation in |
| V52 (O37) | Wild-type sequence | |
| ATCC 25872 (O37) | Wild-type sequence | Wild-type sequence |
| ATCC 25873 (O37) | Wild-type sequence | Wild-type sequence |
Compared to the first sequenced strain of V. cholerae, N16961 (29).
According to a changed annotation (38) (G333 corresponds to G319 in the original annotation provided for strain N16961 [29]).
Bacterial strains (V. cholerae) and plasmids used in this study
| Strain or plasmid | Genotype/description | Internal strain no. | Reference(s) or source |
|---|---|---|---|
| Strains | |||
| A1552 (WT) | Wild type, O1 El Tor Inaba; Rifr | MB_1 | |
| A1552-Tn | A1552 containing mini-Tn | MB_3420 | |
| C6706 (strain #1–7) | MB_1144 (#1), MB_1990 (#2), MB_2599 (#3), MB_3087 (#4), MB_3594 (#5), MB_3601 (#6), MB_4242 (#7) | Obtained from diverse laboratories in North America and Europe | |
| C6706#2-Tn | C6706#2 containing mini-Tn | MB_4146 | This study |
| C6706#3-Tn | C6706#3 containing mini-Tn | MB_4148 | This study |
| C6706#4-Tn | C6706#4 containing mini-Tn | MB_4150 | This study |
| C6706#5-Tn | C6706#5 containing mini-Tn | MB_4152 | This study |
| C6706#6-Tn | C6706#6 containing mini-Tn | MB_4154 | This study |
| N16961 | N16961, | MB_2 | |
| N16961-rep | N16961, | MB_2254 | |
| C6709 | MB_1503 | ||
| E7946 | MB_2600 | ||
| ATCC 25872 | MB_276 | ||
| ATCC 25873 | MB_277 | ||
| DRC-193A | MB_1954 | ||
| P27459 | MB_1504 | ||
| V52 | MB_1510 | ||
| O395 | MB_1147 | ||
| 569B | MB_1148 | ||
| Plasmids | |||
| pUX-BF13 | MB_457 | ||
| pGP704-mTn | pGP704 with mini-Tn | MB_3664 |
Amp, ampicillin; Gent, gentamicin; Rif, rifampin; Str, streptomycin.